References
- Andrey, J. and Saven, A. (2001) "Therapeutic advances in the treatment of hairy cell leukemia", Leukemia Research, 25, 361 — 368.
- Magee, M.J., McKenzie, S., Filippa, D.A., Arlin, Z.A., Gee, T.S. and Clarkson, B.D. (1985) "Hairy cell leukemia: durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients", Cancer, 56, 2557–2562.
- Ratain, M.J., Golomb, H.M., Vardiman, J.W., Westbrook, C.A., Barker, C., Hooberman, A., et al. (1988) "Relapse after interferon a-2b therapy for hairy cell leukemia: Analysis of diagnostic variables", Journal of Clinical Oncology, 6, 1714 — 1721.
- Flinn, I.W., Kopecky, K.J., Foucar, K., Head, D., Bennett, J.M., Hutchison, R., et al. (2000) "Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin", Blood, 96, 2981–2986.
- Saven, A., Burian, C., Koziol, J.A. and Piro, L.D. (1998) "Long-term follow-up of patients with hairy cell leukemia after cladribine treatment", Blood, 92, 1918–1926.
- Au, WY., Klasa, R.J., Gallagher, R., Le, N., Gascoyne, R.D. and Connors, J.M. (1998) "Second malignancies in patients with hairy cell leukemia in British Columbia: A 20-year experience", Blood, 92, 1160 — 1164.
- Jacobs, R.H., Yokes, E.E. and Golomb, H.M. (1985) "Second malignancies in hairy cell leukemia", Cancer, 56, 1462–1467.
- Kampmeier, P., Spielberger, R., Dickstein, J., Mick, R., Golomb, H. and Vardiman, J.W. (1994) "Increased incidence of second neoplasms in patients treated with interferon a 2b for hairy cell leukemia: A clinicopathologic assessment", Blood, 83, 2931 — 2938.
- Ruco, L.P., Procopio, A., Maccallini, V., Calogero, A., Uccini, S., Armin°, L., et al. (1983) "Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia", Blood, 61, 1132 — 1137.
- Goodman, G.R., Burian, C., Koziol, J.A. and Saven, A. (2003) "Extended follow-up of patients with hairy cell leukemia after treatment with cladribine", Journal of Clinical Oncology, 21, 891 — 896.
- Federico, M., Zinzani, P.L., Frassoldati, A., Vinceti, M., Mode, A., Armin°, L., et al. (2002) "Risk of second cancer in patients with hairy cell leukemia: Long-term follow-up", Journal of Clinical Oncology, 20, 638–646.
- Cheson, B.D., Vena, D.A., Barrett, J. and Freidlin, B. (1999) "Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias", Journal of Clinical Oncology, 17, 2454–2460.
- Stewart, D.J. and Keating, M.J. (1982) "Second malignancies in hairy cell leukemia (leukemic reticuloendotheliosis)", American Journal of Hematology, 13, 167— 169.
- Al-Fiar, F., Meharchand, J., Curtis, J. and Lipton, J.H. (1999) "Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature", Leukemia Research, 23, 719 —721.
- Seshadri, P. (2000) "Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine", Leukemia Research (letter), 24, 637.
- Spielberger, R.T., Dickstein, J.I., LeBeau, MM., Larson, R.A., Daly, KM., Vardiman, J.W., et al. (1993) "Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leuke-mia", British Journal of Haematology, 83, 519–520.
- Todd, S.A., Morris, T.C.M. and Alexander, H.D. (2002) "Myelo-dysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2-deoxycoformycin", Leukemia and Lymphoma, 43, 1343–1344.